John R. Sims

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Donanemab in Early Alzheimer’s Disease

Mark A. Mintun, Albert Lo, Cynthia Evans et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

Life Sciences, Neurobiology, Neurology +17

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf et al. · Nature Medicine · 2020 · 803 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

Shorena Janelidze, Erik Stomrud, Ruben Smith et al. · Nature Communications · 2020 · 453 citations · Full text

Medicine, Neurology, Neuroscience +14

ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes

John R. Sims, Leila Rezai Gharai, Pamela W. Schaefer et al. · Neurology · 2009 · 413 citations

Medicine, Cardiology, Clinical Cardiology +11